NASDAQ: HCWB
Hcw Biologics Inc Stock Ownership - Who owns Hcw Biologics?

Insider buying vs selling

Have Hcw Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lee FlowersSVP2026-07-297,736$2.59
$20.00kBuy
Scott T. GarrettDirector2026-07-297,736$2.59
$20.00kBuy
Hing C. WongCEO2026-07-2923,210$2.59
$60.00kBuy
Rebecca ByamChief Financial Officer2026-05-2214,235$1.41
$20.00kBuy
Scott T. GarrettDirector2026-05-22177,936$1.41
$250.00kBuy
Hing C. WongChief Executive Officer2026-05-22113,879$1.41
$160.00kBuy

1 of 1

HCWB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HCWB insiders and whales buy or sell their stock.

HCWB Shareholders

What type of owners hold Hcw Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott T. Garrett14.74%270,590$573.65kInsider
Hing C. Wong6.85%125,845$266.79kInsider
Peter Rhode4.22%77,500$164.30kInsider
Rebecca Byam3.12%57,245$121.36kInsider
Jinan Jiao2.46%45,141$95.70kInsider
Lisa M. Giles1.95%35,815$75.93kInsider
Lee Flowers0.47%8,691$18.42kInsider
Gary M. Winer0.22%4,075$8.64kInsider
Rick S. Greene0.11%2,066$4.38kInsider
Janstr0.00%52$110.24Institution

1 of 3

HCWB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCWB0.01%34.14%Net BuyingNet Buying
SXTP0.01%99.99%Net BuyingNet Buying
SILO0.01%13.97%Net Buying
VIVS0.00%100.00%Net Selling
PHGE0.00%100.00%Net Selling

Hcw Biologics Stock Ownership FAQ

Who owns Hcw Biologics?

Hcw Biologics (NASDAQ: HCWB) is owned by 0.01% institutional shareholders, 34.14% Hcw Biologics insiders, and 65.85% retail investors. Scott T. Garrett is the largest individual Hcw Biologics shareholder, owning 270,590.00 shares representing 14.74% of the company. Scott T. Garrett's Hcw Biologics shares are currently valued at $589.89k.

If you're new to stock investing, here's how to buy Hcw Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.